Get the Stockscreener App
98.92
6.34%
5.90
After Hours:
99.00
0.08
+0.08%
Guardant Health Inc stock is traded at $98.92, with a volume of 2.68M.
It is up +6.34% in the last 24 hours and up +57.42% over the past month.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
See More
Previous Close:
$93.02
Open:
$94.07
24h Volume:
2.68M
Relative Volume:
1.01
Market Cap:
$12.34B
Revenue:
$692.26M
Net Income/Loss:
$-512.41M
P/E Ratio:
-23.33
EPS:
-4.24
Net Cash Flow:
$-274.36M
1W Performance:
+39.62%
1M Performance:
+57.42%
6M Performance:
+111.14%
1Y Performance:
+330.09%
1-Day Range:
$92.57
$99.23
1-Week Range:
$68.02
$99.23
52-Week Range:
$22.91
$99.23
Guardant Health Inc Stock (GH) Company Profile
Name
Guardant Health Inc
Sector
Industry
Phone
855-698-8887
Address
3100 HANOVER STREET, PALO ALTO
Compare GH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
98.92 | 11.72B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-22-25 | Resumed | Wells Fargo | Overweight |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-28-24 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-24-24 | Resumed | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Guggenheim | Neutral |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-13-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-27-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-26-23 | Upgrade | Citigroup | Neutral → Buy |
| May-05-23 | Initiated | UBS | Buy |
| Mar-09-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Nov-01-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-19-22 | Initiated | Craig Hallum | Buy |
| Oct-06-22 | Initiated | Stephens | Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | Piper Sandler | Overweight |
| Apr-28-22 | Resumed | BTIG Research | Buy |
| Feb-24-22 | Reiterated | Canaccord Genuity | Buy |
| Feb-24-22 | Reiterated | Citigroup | Buy |
| Feb-24-22 | Reiterated | Cowen | Outperform |
| Feb-24-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-24-22 | Reiterated | SVB Leerink | Outperform |
| Feb-24-22 | Reiterated | Stifel | Buy |
| Feb-24-22 | Reiterated | Wells Fargo | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| Jun-03-21 | Initiated | Goldman | Buy |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-11-21 | Initiated | Stifel | Buy |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jun-12-20 | Initiated | BTIG Research | Buy |
| Feb-21-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Aug-07-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-16-19 | Initiated | Canaccord Genuity | Buy |
| Apr-10-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-28-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-29-18 | Initiated | BofA/Merrill | Neutral |
| Oct-29-18 | Initiated | JP Morgan | Overweight |
| Oct-29-18 | Initiated | William Blair | Outperform |
View All
Guardant Health Inc Stock (GH) Latest News
Guardant Health stock hits 52-week high at 95.99 USD - Investing.com
Guardant Health Inc. stock trendline breakdownWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Will Guardant Health Inc. stock go up soonJuly 2025 Trends & Fast Gaining Stock Strategy Reports - newser.com
How supply shortages influence Guardant Health Inc. (5GH) stock - newser.com
How Guardant Health Inc. (5GH) stock correlates with oil marketsWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Sentiment analysis tools applied to Guardant Health Inc.Trade Volume Summary & Weekly Top Gainers Alerts - newser.com
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN
United States ESR1 Mutated Metastatic Breast Cancer - openPR.com
Can Guardant Health Inc. (5GH) stock deliver strong annual returns2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Relative strength of Guardant Health Inc. in sector analysisTrade Signal Summary & Daily Profit Focused Stock Screening - newser.com
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosPrice Action & Reliable Volume Spike Trade Alerts - newser.com
Can volume confirm reversal in Guardant Health Inc.Weekly Market Summary & Comprehensive Market Scan Insights - newser.com
Can Guardant Health Inc. stock deliver consistent earnings growthJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Is Guardant Health Inc 5GH a good long term investmentCapital Gains Strategies & Rapid Portfolio Expansion - earlytimes.in
Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio?Teradyne (NASDAQ:TER), Guardant Health (NASDAQ:GH), C.H. Robinson Worldwide (NASDAQ:CHRW), Credo Techn - Benzinga
Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st
Guardant Health, Inc. $GH Holdings Trimmed by Pier Capital LLC - MarketBeat
Using AI based signals to follow Guardant Health Inc.Weekly Profit Report & Long-Term Capital Growth Ideas - newser.com
Why Guardant Health Inc. (5GH) stock could outperform next yearJuly 2025 Short Interest & Consistent Income Trade Recommendations - newser.com
Guardant Health Stock Soars 29% In A Single Week, Wait For A Dip To Buy The Stock - Trefis
Can Guardant Health Inc. stock attract ESG capital inflows2025 Earnings Impact & Fast Moving Stock Watchlists - newser.com
Guardant Health Hits Day High with 27.87% Surge in Stock Price - Markets Mojo
This Is Why Guardant Health Stock (GH) Surged 30% Today - MSN
Guardant Health Stock Up 29% in One Week, Wait For A Dip To Buy The Stock - Trefis
Guardant Health Stock Shares Rally 29% In A Week, Wait For A Dip To Buy The Stock - Trefis
Guardant Health, Inc. (GH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Guardant Health, Inc. (GH) Stock forecasts - Yahoo! Finance UK
Is Guardant Health Inc. (5GH) stock positioned for digital growth eraEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
Analysts Are Upgrading Guardant Health, Inc. (NASDAQ:GH) After Its Latest Results - 富途牛牛
Jennison Associates LLC Acquires New Shares in Guardant Health, Inc. $GH - MarketBeat
Ethic Inc. Buys Shares of 4,261 Guardant Health, Inc. $GH - MarketBeat
Y Intercept Hong Kong Ltd Makes New $2.38 Million Investment in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Stock Surges 29% In A Single Week, Wait For A Dip To Buy The Stock - Trefis
Guardant Health’s Q3 2025 Earnings: Strong Growth Amid Challenges - The Globe and Mail
Guardant Health Stock Surges 28% In A Single Day, Wait For A Dip To Buy The Stock - Trefis
Evercore ISI Raises Guardant Health (NASDAQ:GH) Price Target to $90.00 - MarketBeat
Guardant Health (NASDAQ:GH) Shares Gap Up After Analyst Upgrade - MarketBeat
Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts (NASDAQ:GH) - Seeking Alpha
BTIG Research Issues Positive Forecast for Guardant Health (NASDAQ:GH) Stock Price - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Q3 2025 Earnings Call Transcript - Insider Monkey
Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates - MSN
Emerald Mutual Fund Advisers Trust Increases Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable - simplywall.st
How to use Fibonacci retracement on Guardant Health Inc.Quarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Is Guardant Health Inc. (5GH) stock a top hedge fund pickMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
How risky is Guardant Health Inc. stock nowLong Setup & AI Enhanced Market Trend Forecasts - newser.com
Why Guardant Health Inc. stock is recommended by analystsRate Cut & Consistent Growth Stock Picks - newser.com
Guardant Health Inc Stock (GH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):